Tania Garfias-Veitl
Tania Garfias-Veitl is an expert in Cardiology at Universitätsmedizin Göttingen (Germany). Tania Garfias-Veitl has authored 29 publications, the most recent in 2026. SLR score: 77 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Neurology - Pediatrics - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2021 - 2026
Number : 29
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Iron Deficiency and Bone Metabolism in Heart Failure. PMID 42613025 — serum, vitamins, heart failure, heart, bone density, plasma, iron deficiencies | Eur J Heart Fail | 2026 | 0 |
| Skeletal Muscle Mass Modifies the Prognostic Impact of LDL Cholesterol in Chronic Heart Failure. PMID 41543036 — mortality, cholesterol, ldl, muscles, heart failure, heart, cholesterol, muscle, skeletal, cachexia, sarcopenia | J Cachexia Sarcopenia Muscle | 2026 | 0 |
| Effect of Positive End-Expiratory Pressure on Cardiac Index and Right Ventricular Performance in Ventilated Children Post-Cardiac Surgery. PMID 41416857 — heart defects, congenital, research design, lung, lung compliance, critical care, cardiac output, child | Pediatr Crit Care Med | 2025 | 0 |
| Physical activity and its effects in myasthenia gravis: a patient-reported study on habits and impact. PMID 41408204 — exercise, quality of life, pain, nervous system diseases, myasthenia gravis | BMC Neurol | 2025 | 0 |
| Different Pattern in Circulating MicroRNA-22-3p Levels Between Patients With Primary Versus Secondary Sarcopenia. PMID 41239553 — muscles, heart failure, micrornas, muscle, skeletal, circulating microrna, sarcopenia | Aging Cell | 2025 | 0 |
LeadR Networks
Main global connection map